OncoSec Medical Incorporated
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$34,179,634 over the previous period. Total operating expenses were $37,012,062.

Profit Margin

OncoSec Medical Incorporated (NASDAQ:ONCS): Profit margin
2013 0 -7.15M
2014 0 -12.01M
2015 0 -21.24M
2016 0 -26.88M
2017 0 -21.44M
2018 0 -39.13M
2019 0 -30.27M
2020 0 -42.25M
2021 0 -45.16M
2022 0 -34.17M

ONCS Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
0000000000
Cost of revenue
0000000000
Gross profit
0000000000
Operating exp.
Research and development
25.82M34.09M25.09M18.44M17.41M11.95M14.74M13.13M5.79M3.15M
Selling and marketing
0000000000
Total operating expenses
37.01M48.38M43.40M30.41M36.10M21.44M26.88M21.24M11.94M7.06M
Operating income
-37.01M-48.38M-43.40M-30.41M-36.10M-21.44M-26.88M-21.24M-11.94M-7.06M
Other income (expenses), net
-501.72K800.14K283.07K141.92K-3.03M000-20.68K-83.21K
Income before tax
-37.51M-47.57M-43.12M-30.27M-39.13M-21.44M-26.88M-21.24M-11.97M-7.14M
Income tax expense
-3.33M-2.41M-872.58K1.29K6801.39K2.46K1.96K41.77K2K
Net income
-34.17M-45.16M-42.25M-30.27M-39.13M-21.44M-26.88M-21.24M-12.01M-7.15M
Earnings per share
Basic EPS
-19.13-30.2-56.22-94.43-214.59-233.73-358.2-367.73-277.38-295.25
Diluted EPS
-19.13-30.2-56.22-94.43-214.59-233.73-358.2-367.73-277.38-295.25
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source